AdaptHealth Corp.

AI Score

XX

Unlock

10.79
0.15 (1.41%)
At close: Mar 31, 2025, 12:38 PM

AdaptHealth Statistics

Share Statistics

AdaptHealth has 134.87M shares outstanding. The number of shares has increased by -1.35% in one year.

Shares Outstanding 134.87M
Shares Change (YoY) -1.35%
Shares Change (QoQ) 0.06%
Owned by Institutions (%) 97.57%
Shares Floating 86.6M
Failed to Deliver (FTD) Shares 14
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 9.92M, so 7.37% of the outstanding shares have been sold short.

Short Interest 9.92M
Short % of Shares Out 7.37%
Short % of Float 11.4%
Short Ratio (days to cover) 6.01

Valuation Ratios

The PE ratio is 14.08 and the forward PE ratio is 10.35. AdaptHealth's PEG ratio is -0.12.

PE Ratio 14.08
Forward PE 10.35
PS Ratio 0.39
Forward PS 0.2
PB Ratio 0.81
P/FCF Ratio 5.4
PEG Ratio -0.12
Financial Ratio History

Enterprise Valuation

AdaptHealth Corp. has an Enterprise Value (EV) of 3.2B.

EV / Earnings 35.34
EV / Sales 0.98
EV / EBITDA 10.53
EV / EBIT 12.12
EV / FCF 13.55

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.11.

Current Ratio 1.33
Quick Ratio 1.09
Debt / Equity 0.11
Total Debt / Capitalization 9.53
Cash Flow / Debt 3.28
Interest Coverage 2.08

Financial Efficiency

Return on equity (ROE) is 0.06% and return on capital (ROIC) is 10.54%.

Return on Equity (ROE) 0.06%
Return on Assets (ROA) 0.02%
Return on Capital (ROIC) 10.54%
Revenue Per Employee $310,569.05
Profits Per Employee $8,611.62
Employee Count 10,500
Asset Turnover 0.73
Inventory Turnover 18.45

Taxes

Income Tax 41.24M
Effective Tax Rate 0.3

Stock Price Statistics

The stock price has increased by -7.65% in the last 52 weeks. The beta is 1.3, so AdaptHealth's price volatility has been higher than the market average.

Beta 1.3
52-Week Price Change -7.65%
50-Day Moving Average 10.05
200-Day Moving Average 10.3
Relative Strength Index (RSI) 59.34
Average Volume (20 Days) 1.5M

Income Statement

In the last 12 months, AdaptHealth had revenue of 3.26B and earned 90.42M in profits. Earnings per share was 0.68.

Revenue 3.26B
Gross Profit 681.09M
Operating Income 263.73M
Net Income 90.42M
EBITDA 303.37M
EBIT 263.73M
Earnings Per Share (EPS) 0.68
Full Income Statement

Balance Sheet

The company has 109.75M in cash and 165.41M in debt, giving a net cash position of -55.67M.

Cash & Cash Equivalents 109.75M
Total Debt 165.41M
Net Cash -55.67M
Retained Earnings -562.18M
Total Assets 4.49B
Working Capital 188.8M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 541.84M and capital expenditures -306.06M, giving a free cash flow of 235.78M.

Operating Cash Flow 541.84M
Capital Expenditures -306.06M
Free Cash Flow 235.78M
FCF Per Share 1.76
Full Cash Flow Statement

Margins

Gross margin is 20.89%, with operating and profit margins of 8.09% and 2.77%.

Gross Margin 20.89%
Operating Margin 8.09%
Pretax Margin 4.17%
Profit Margin 2.77%
EBITDA Margin 9.3%
EBIT Margin 8.09%
FCF Margin 7.23%

Dividends & Yields

AHCO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield 6.4%
FCF Yield 16.45%
Dividend Details

Analyst Forecast

The average price target for AHCO is $14, which is 31.7% higher than the current price. The consensus rating is "Buy".

Price Target $14
Price Target Difference 31.7%
Analyst Consensus Buy
Analyst Count 5
Stock Forecasts

Scores

Altman Z-Score 1.26
Piotroski F-Score 8